Navigation Links
Chemistry professor 1 of only 3 at UH to achieve prestigious AAAS status
Date:12/22/2008

HOUSTON, Dec. 22, 2008 B. Montgomery "Monte" Pettitt, the Hugh Roy and Lillie Cranz Cullen Professor of Chemistry and Professor of Physics, Computer Science, Biology and Biochemistry at the University of Houston, has been awarded the distinction of Fellow from the American Association for the Advancement of Science (AAAS).

Of this year's 486 Fellows, Pettitt is among Texas' 16 honorees, six of whom are from Houston institutions. He is one of only three researchers in UH's history to hold this distinction. Part of a tradition dating back to 1874, AAAS members are awarded this appointment by their peers for their scientifically or socially distinguished efforts to advance science or its applications. Along with the other new Fellows for 2008, Pettitt will be recognized Saturday, Feb. 14, during the 2009 AAAS Annual Meeting in Chicago.

"Being named an AAAS Fellow is among the top honors that a scientist can receive, and such awards are a factor considered in determining the ranking of a research university," said John Bear, dean of the College of Natural Sciences and Mathematics at UH. "This achievement will no doubt put Monte in a position to be considered for subsequent distinguished awards, such as those bestowed by the Academy of Arts and Sciences and the National Academy of Sciences."

As part of the section on chemistry, Pettitt was elected as an AAAS Fellow for distinguished contributions to computational and theoretical chemistry, particularly for discoveries concerning the thermodynamics of aqueous solutions and the properties of biopolymers.

In conducting his research, he analyzes the relationships between energy and structures of biomolecules in water, as well as looks into properties found in other molecules produced by living organisms. This helps him to come up with principles for designing new biosensors and new therapeutics.

"My research ranges from modeling the behavior of liquids to eluc
'/>"/>

Contact: Lisa Merkl
lkmerkl@uh.edu
713-743-8192
University of Houston
Source:Eurekalert  

Page: 1 2

Related biology news :

1. International public-private partnership offers new paradigm for medicinal chemistry
2. Biochemistry of human physiology in health and disease is focus of updated clinical text
3. The Camille & Henry Dreyfus Foundation to host important symposium on chemistry and the environment
4. Volcanoes may have provided sparks and chemistry for first life
5. Research center to free chemistry from Earths bonds
6. Food, health get top billing at national chemistry meeting
7. Catalysis takes center stage at chemistry conference
8. UCSB chemistry professor receives top military award for life-saving gauze
9. Global Challenges/Chemistry Solutions debuts with focus on drinking water
10. Yales Anastas honored for leadership in founding of green chemistry
11. 14-year-old CEO makes chemistry a game with Elementeo
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Chemistry professor 1 of only 3 at UH to achieve prestigious AAAS status
(Date:10/16/2014)... , October 16, 2014 NXT-ID, Inc. ... the "Company"), a biometric authentication company focused on the ... leading edge technologies including Wocket™, the Smart Wallet, at ... Conferenece. FiRe is a leading global conference on the ... Hosted by Mark Anderson , founder and publisher ...
(Date:10/15/2014)... to an unexpected extent. The outbreak does not follow ... shows a new disease dynamic in regions, where it ... German National Academy of Sciences Leopoldina, acatech – the ... of the German Academies of Sciences and Humanities have ... In the statement the academies call for the following ...
(Date:10/14/2014)... prostate cancer tumors scavenge and hoard copper that is ... may be a fatal weakness. , Researchers at ... cancer cells by delivering a trove of copper along ... brimming with the mineral, leaving non-cancer cells healthy. , ... available for other uses, could soon be tested in ...
Breaking Biology News(10 mins):NXT-ID Inc. to Present at 13th Annual FiRe Conference 2NXT-ID Inc. to Present at 13th Annual FiRe Conference 3Academies call for consequences from the Ebola virus epidemic 2Academies call for consequences from the Ebola virus epidemic 3Academies call for consequences from the Ebola virus epidemic 4Academies call for consequences from the Ebola virus epidemic 5Prostate cancer's penchant for copper may be a fatal flaw 2
... characterise their Zap-It! product, which uses the tiny electric ... itching caused by insect bites - such as those from ... that is based around a similar piezoelectric mechanism to that ... a medical device, currently available to buy in high street ...
... Molecular biologist Ichiro Matsumoto, Ph.D., of the Monell Center, ... Young Investigators in Gustation, awarded annually by the Association ... who is an emerging leader in the field of ... the understanding of the organization, relationships and connectivity of ...
... of the potentially deadly antibiotic-resistant bacterium known as MRSA ... a new study involving two Northern Arizona University researchers., ... for Microbial Genetics and Genomics, and Lance Price, NAU ... Microbiology and Environmental Health at the Translational Genomics Research ...
Cached Biology News:Zapping mosquito bites 2Evolution of staph 'superbug' traced between humans and food animals 2
(Date:10/22/2014)... Shimadzu Scientific Instruments introduces its Open Solution QuantAnalytics(TM) ... management and clinical markets. The software increases the speed ... users to highlight and review results that are of ... to filter results by group or based on a ... need to sift through analytes of no interest. In ...
(Date:10/22/2014)... UAE (PRWEB) October 22, 2014 Grace ... science and healthcare projects, announces the addition of ... DCH to its advisory team. Dr. Siddiqui will provide ... , A graduate of University College Medical ... subsequently degreed in medicine in 2001. With further certification ...
(Date:10/22/2014)... , Oct. 22, 2014 /PRNewswire/ - iCo Therapeutics ("iCo" ... announced next steps for its Oral Amphotericin B ... its in vitro work involving samples ... now plans to complete pre clinical studies and ... Phase 1A clinical trial, utilizing approximately $700,000 of ...
(Date:10/20/2014)... The report “Pharmacy Automation Systems Market ... Labeling Systems, Table-top Counters) by End-user (Inpatient Pharmacy ... Trends to 2019” analyzes and studies the major ... Europe, Asia-Pacific, and the Rest of the World ... figures spread through 300 pages and in-depth TOC ...
Breaking Biology Technology:Shimadzu Releases QuantAnalytics Open Access LCMS Software Package for Clinical Applications 2Dr. Yousef Siddiqui joins the Grace Century Advisory Team 2iCo Therapeutics Announces Advancement of Oral Amphotericin B Program 2iCo Therapeutics Announces Advancement of Oral Amphotericin B Program 3Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 2Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 3Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 4
... ... Intellectual Property, FULLERTON, Calif., Nov. 28 Beckman Coulter,Inc. ... and,automate complex biomedical testing announced today that it has entered,into an ... spin out of Lumigen, Inc., effected prior to Beckman,Coulter,s acquisition of ...
... Cambridge Research &,Instrumentation (CRi) announced today that ... of allowance for their patent application number,10/669,101, for ... patent covers the use of multispectral imaging combined,with ... of,fluorophores in a living mammal. The unmixing of ...
... 1-41 has significant ... and anti-amnesic benefits, GENEVA, Nov. 28 /PRNewswire-FirstCall/ - ... announce promising developments with,ANAVEX 1-41, the company,s lead drug ... 1-41 prevented oxidative stress,which damages and destroys cells and ...
Cached Biology Technology:Beckman Coulter to Acquire Exclusive Rights to Break-Through Technologies 2US Patent and Trademark Office Allows CRi's Patent Application for Spectral Imaging of Deep Tissue 2Anavex advances drug candidate for treatment of Alzheimer's disease 2Anavex advances drug candidate for treatment of Alzheimer's disease 3Anavex advances drug candidate for treatment of Alzheimer's disease 4Anavex advances drug candidate for treatment of Alzheimer's disease 5
...
...
Immunogen: Peptide corresponding to amino acid residues from the N-terminal region of human thyroid hormone receptor, alpha1/alpha2-isotype. Storage: -20 C, Avoid Freeze/Thaw Cycles...
Antibodies were affinity purified using epitopes specific to QKI immobilized on solid support....
Biology Products: